Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000950170-22-025513

10% owner acquired 888,130 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-17 Conversion : show line 1 in the form +888,130 888,130 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-17 Conversion : show line 2 in the form Series B Preferred Stock −2,190,131 0 D
Loading xslF345X03/ownership.xml…